Tag: Precedence Research
ASX biotech firm Noxopharm’s new mRNA enhancer to make vaccines safer
Australian biotech company Noxopharm Limited unveiled today the development of a new mRNA vaccine enhancer that will make mRNA vaccines safer by reducing inflammation associated with mRNA vaccines.
Report: 3D printers market size to reach USD 88.61b by 2032
The market for 3D printers will be worth approximately USD 88.61 billion by 2032 and will grow at a CAGR of 17.54 per cent between 2023 and 2032, according to a recent report by Precedence Research.
Featured Article
Manufacturers should do this sooner rather than later, says precision engineer
Australian precision engineering and industrial instrumentation company CENMAC implemented ERP software when it was still a one-man operation. “I couldn’t imagine us growing to this size without MRPeasy,” says Jason Ford, Founder.
